Comparison of characteristics from White- and Black-Americans with venous thromboembolism: A cross-sectional study

American Journal of Hematology

Volumn 85, Issue 7, 2010, Pages 467-471

  Heit, John A ^a   Beckman, Michele G ^b   Bockenstedt, Paula L ^c   Grant, Althea M ^b   Key, Nigel S ^d   Kulkarni, Roshni ^e   Manco Johnson, Marilyn J ^f   Moll, Stephan ^d   Ortel, Thomas L ^g   Philipp, Claire S ^h  

^a MAYO CLINIC   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f Mountain States Regional Hemophilia and Thrombosis Center   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HORMONE; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CAUCASIAN; CHRONIC KIDNEY DISEASE; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HEMODIALYSIS PATIENT; HORMONAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SICKLE CELL ANEMIA; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ETHNOLOGY; PROSPECTIVE STUDY; STATISTICS;

AFRICAN AMERICANS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INCIDENCE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 77954889114     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21735     Document Type: Article

References (52)

1. Anderson F, Wheeler H, Goldberg R, et al. Physician practices in the prevention of venous thromboembolism. Ann Int Med 1991;115:591-595.
2. Cogo A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Int Med 1994;154:164-168. (Pubitemid 24032190)
3. Heit J, Silverstein M, Mohr D, et al. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Int Med 2000;160:809-815. (Pubitemid 30165241)
4. Samama M-M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. Arch Int Med 2000;160:3415-3420.
5. Tsai A, Cushman M, Rosamond W, et al. Cardiovascular risk factors and venous thromboembolism incidence. Arch Int Med 2002;162:1182-1189.
6. Dowling N, Austin H, Dilley A, et al. The epidemiology of venous thromboembolism in Caucasians and African-Americans: The GATE Study. J Thromb Haemost 2003;1:80-87.
7. White R, Zhou H, Romano P. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Int Med 1998;128:737-740. (Pubitemid 28204865)
8. White R, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005;93:298-305.
9. Schneider D, Lilienfeld D, Im W. The epidemiology of pulmonary embolism: Racial contrasts in incidence and in-hospital case fatality. J Natl Med Assoc 2006;98:1967-1972. (Pubitemid 44955943)
10. Keenan C, White R. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 2007;13:377-383. (Pubitemid 47472297)
11. Koster T, Rosendaal F, de Ronde H, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503-1506. (Pubitemid 23362165)
12. Svensson P, Dahlbäck B. Resistance to activated protein C as a basis of venous thrombosis. N Engl J Med 1994;330:517-522. (Pubitemid 24058953)
13. Ridker P, Hennekens C, Selhub J. Interrelation of hyperhomocyst (e) inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997;95:1777-1782. (Pubitemid 27164393)
14. Heit J, Sobell J, Li H, et al. The incidence of venous thromboembolism among Factor V Leiden carriers: A community-based cohort study. J Thromb Haemost 2005;3:305-311. (Pubitemid 41623619)
15. Poort S, Rosendaal F, Reitsma P, et al. A common genetic variation in the 3′- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703. (Pubitemid 26383091)
16. Margaglione M, Brancaccio V, Giuliani N, et al. Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant. Ann Int Med 1998;129:89-93. (Pubitemid 28337249)
17. Hooper W, Dilley A, Ribeiro M, et al. A racial difference in the prevalence of the Arg506→Gln mutation. Thromb Res 1996;81:577-581. (Pubitemid 126352865)
18. Dilley A, Austin H, Hooper W, et al. Prevalence of the prothrombin 20210 G-to- A variant in blacks: Infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med 1998;132:452-455. (Pubitemid 28564700)
19. Dowling N, Beckman M, Manco-Johnson M, et al. The U.S. Thrombosis and Hemostasis Centers pilot sites program. J Thromb Thrombolysis 2007;23:1-7. (Pubitemid 46252285)
20. Miyakis S, Lockshin M, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
21. Heit J, Silverstein M, Mohr D, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Arch Int Med 1999;159:445-453. (Pubitemid 29108909)
22. Aujesky D, Long J, Fine M, et al. African American race was associated with an increased risk of complications following venous thromboembolism. J Clin Epidemiol 2007;60:410-416. (Pubitemid 46341707)
23. Stein P, Kayali F, Olson RE. Estimated case fatality rate of pulmonary embolism, 1979 to 1998. Am J Cardiol 2004;93:1197-1199.
24. Austin H, Key N, Benson J, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007;110:908-912. (Pubitemid 47267428)
25. Copur A, Smith P, Gomez V, et al. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS 2002;16:205-209. (Pubitemid 34478160)
26. Ginsburg K, Liang M, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Int Med 1992;117:997-1002.
27. Heit J, Leibson C, Ashrani A, et al. Is diabetes mellitus an independent risk factor for venous thromboembolism?: A population-based case-control study. Arterioscler Thromb Vasc Biol 2009;29:1399-1405.
28. Center for Disease Control and Prevention C. Health disparities experienced by black or African Americans-United States. MMWR Morb Mortal Wkly Rep 2005;54:1-3.
29. Austin H, Hooper W, Lally C, et al. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J Epidemiol 2000;53:997-1001.
30. Dilley A, Austin H, Hooper W, et al. Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol 1998;147:30-35. (Pubitemid 28034609)
31. Dilley A, Hooper W, El-Jamil M, et al. Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C→T677) and cystathione betasynthase (CBS G→A919, CBS T→c833) are not associated with myocardial infarction in African Americans. Thromb Res 2001;130:109-115. (Pubitemid 32701948)
32. Hooper W, Dilley A, Austin H, et al. Absence of mutations at APC cleavage sites Arg306 in factor V and Arg336, Arg562 in factor VIII in African-Americans. Thromb Haemost 1998;79:236.
33. Hooper W, Lally C, Austin H, et al. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 1999;116:880-886. (Pubitemid 29491853)
34. Hooper W, Lally C, Austin H, et al. The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 2000;99:223-230.
35. Folsom A, Wu K, Davis C, et al. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991;91:191-205.
36. Folsom A, Wu K, Conlan M, et al. Distributions of hemostatic variables in blacks and whites: Population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis 1992;2:35-46.
37. Conlan M, Folsom A, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70:380-385.
38. Lutsey P, Cushman M, Steffen L, et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: The MESA study. J Thromb Haemost 2006;4:2629-2635.
39. Souto J, Almasy L, Borrell M, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: The GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 2000;67:1452-1459.
40. de Lange M, Snieder H, Ariens R, et al. The genetics of haemostasis: A twin study. Lancet 2001;357:101-105.
41. Ariëns R, de Lange M, Snieder H, et al. Activation markers of coagulation and fibrinolysis in twins: Heritability of the prethrombotic state. Lancet 2002;359:667-671.
42. Peetz D, Victor A, Adams P, et al. Genetic and environmental influences on the fibrinolytic system: A twin study. Thromb Haemost 2004;92:344-351.
43. Bladbjerg E, de Maat M, Christensen K, et al. Genetic influence on thrombotic risk markers in the elderly - A Danish twin study. J Thromb Haemost 2006;4:599-607.
44. Dowling N, Lally C, Miller C, et al. Associations of Factor VIII (FVIII) and von Willebrand Factor Antigen (VWF:Ag) with race, age, ABO blood group and co-morbid conditions. J Thromb Haemost 2005;3(Suppl 1):PO649.
45. Pieper C, Rao K, Currie M, et al. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol Ser A: Biol Sci Med Sci 2000;55:M649-M657.
46. Lange L, Reiner A, Carty C, et al. Common genetic variants associated with plasma fibrin D-dimer concentration in older European- and African-American adults. J Thromb Haemost 2008;6:654-659.
47. Patel R, Ford E, Thumpston J, et al. Risk factors for venous thrombosis in the black population. Thromb Haemost 2003;90:835-838.
48. Patel R, Ford E, Thumpston J, et al. Coagulation factor levels and venous thrombosis in the black population. Thromb Haemost 2004;91:828-830.
49. Miletich J, Sherman L, Broze GJ. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987;317:991-996.
50. Tait R, Walker I, Reitsma P, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995;73:87-93.
51. van Sluis G, Sohne M, El Kheir D, et al. Family history and inherited thrombophilia. J Thromb Haemost 2006;4:2182-2187.
52. Heit J, O'Fallon W, Petterson T, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study. Arch Int Med 2002;162:1245-1248.